Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Erythromyeloid-Derived TREM2: A Major Determinant of Alzheimer's Disease Pathology in Down Syndrome.

Raha-Chowdhury R, Henderson JW, Raha AA, Stott SRW, Vuono R, Foscarin S, Wilson L, Annus T, Fincham R, Allinson K, Devalia V, Friedland RP, Holland A, Zaman SH.

J Alzheimers Dis. 2018;61(3):1143-1162. doi: 10.3233/JAD-170814.

2.

CD24 expression does not affect dopamine neuronal survival in a mouse model of Parkinson's disease.

Stott SR, Hayat S, Carnwath T, Garas S, Sleeman JP, Barker RA.

PLoS One. 2017 Feb 9;12(2):e0171748. doi: 10.1371/journal.pone.0171748. eCollection 2017.

3.

Survival of a Novel Subset of Midbrain Dopaminergic Neurons Projecting to the Lateral Septum Is Dependent on NeuroD Proteins.

Khan S, Stott SR, Chabrat A, Truckenbrodt AM, Spencer-Dene B, Nave KA, Guillemot F, Levesque M, Ang SL.

J Neurosci. 2017 Mar 1;37(9):2305-2316. doi: 10.1523/JNEUROSCI.2414-16.2016. Epub 2017 Jan 27.

4.

Molecular Diversity of Midbrain Development in Mouse, Human, and Stem Cells.

La Manno G, Gyllborg D, Codeluppi S, Nishimura K, Salto C, Zeisel A, Borm LE, Stott SRW, Toledo EM, Villaescusa JC, Lönnerberg P, Ryge J, Barker RA, Arenas E, Linnarsson S.

Cell. 2016 Oct 6;167(2):566-580.e19. doi: 10.1016/j.cell.2016.09.027.

5.

Neuroprotective Effect of TREM-2 in Aging and Alzheimer's Disease Model.

Raha AA, Henderson JW, Stott SR, Vuono R, Foscarin S, Friedland RP, Zaman SH, Raha-Chowdhury R.

J Alzheimers Dis. 2017;55(1):199-217.

PMID:
27662313
6.

A PBX1 transcriptional network controls dopaminergic neuron development and is impaired in Parkinson's disease.

Villaescusa JC, Li B, Toledo EM, Rivetti di Val Cervo P, Yang S, Stott SR, Kaiser K, Islam S, Gyllborg D, Laguna-Goya R, Landreh M, Lönnerberg P, Falk A, Bergman T, Barker RA, Linnarsson S, Selleri L, Arenas E.

EMBO J. 2016 Sep 15;35(18):1963-78. doi: 10.15252/embj.201593725. Epub 2016 Jun 28.

7.

Evidence for a Notch1-mediated transition during olfactory ensheathing cell development.

Miller SR, Perera SN, Benito C, Stott SR, Baker CV.

J Anat. 2016 Sep;229(3):369-83. doi: 10.1111/joa.12494. Epub 2016 Jun 6.

8.

Erratum. Correction to: Dopamine and Huntington's disease.

Schwab LC, Garas SN, Drouin-Ouellet J, Mason SL, Stott SR, Barker RA.

Expert Rev Neurother. 2015;15(11):1367. doi: 10.1586/14737175.2015.1088179. Epub 2015 Nov 2. No abstract available.

PMID:
26523752
9.

The Origin, Development and Molecular Diversity of Rodent Olfactory Bulb Glutamatergic Neurons Distinguished by Expression of Transcription Factor NeuroD1.

Roybon L, Mastracci TL, Li J, Stott SR, Leiter AB, Sussel L, Brundin P, Li JY.

PLoS One. 2015 Jun 1;10(6):e0128035. doi: 10.1371/journal.pone.0128035. eCollection 2015.

10.

Expression and cellular localization of hepcidin mRNA and protein in normal rat brain.

Raha-Chowdhury R, Raha AA, Forostyak S, Zhao JW, Stott SR, Bomford A.

BMC Neurosci. 2015 Apr 21;16:24. doi: 10.1186/s12868-015-0161-7.

11.

Dopamine and Huntington's disease.

Schwab LC, Garas SN, Drouin-Ouellet J, Mason SL, Stott SR, Barker RA.

Expert Rev Neurother. 2015 Apr;15(4):445-58. doi: 10.1586/14737175.2015.1025383. Epub 2015 Mar 16. Review. Erratum in: Expert Rev Neurother. 2015;15(11):1367. Garas, Shaady N [corrected to Garas, Shady N].

PMID:
25773746
12.

The wrong James Parkinson.

Stott SR.

Pract Neurol. 2015 Apr;15(2):148. doi: 10.1136/practneurol-2014-001043. Epub 2015 Jan 5. No abstract available.

PMID:
25561574
13.

The application of optical coherence tomography to image subsurface tissue structure of Antarctic krill Euphausia superba.

Bellini N, Cox MJ, Harper DJ, Stott SR, Ashok PC, Dholakia K, Kawaguchi S, King R, Horton T, Brown CT.

PLoS One. 2014 Oct 13;9(10):e110367. doi: 10.1371/journal.pone.0110367. eCollection 2014.

14.

Time course of dopamine neuron loss and glial response in the 6-OHDA striatal mouse model of Parkinson's disease.

Stott SR, Barker RA.

Eur J Neurosci. 2014 Mar;39(6):1042-56. doi: 10.1111/ejn.12459. Epub 2013 Dec 26.

PMID:
24372914
15.

Foxa1 and foxa2 are required for the maintenance of dopaminergic properties in ventral midbrain neurons at late embryonic stages.

Stott SR, Metzakopian E, Lin W, Kaestner KH, Hen R, Ang SL.

J Neurosci. 2013 May 1;33(18):8022-34. doi: 10.1523/JNEUROSCI.4774-12.2013.

16.

Stem cells and the treatment of Parkinson's disease.

Ali F, Stott SR, Barker RA.

Exp Neurol. 2014 Oct;260:3-11. doi: 10.1016/j.expneurol.2012.12.017. Epub 2013 Jan 6. Review.

PMID:
23298521
17.

Adeno-associated viral vector serotypes 1 and 5 targeted to the neonatal rat and pig striatum induce widespread transgene expression in the forebrain.

Kornum BR, Stott SR, Mattsson B, Wisman L, Ettrup A, Hermening S, Knudsen GM, Kirik D.

Exp Neurol. 2010 Mar;222(1):70-85. doi: 10.1016/j.expneurol.2009.12.009. Epub 2009 Dec 16.

PMID:
20025873
18.

Polyclonal T-cell reconstitution of X-SCID recipients after in utero transplantation of lymphoid-primed multipotent progenitors.

Liuba K, Pronk CJ, Stott SR, Jacobsen SE.

Blood. 2009 May 7;113(19):4790-8. doi: 10.1182/blood-2007-12-129056. Epub 2008 Dec 12.

19.

Targeted in utero delivery of a retroviral vector for gene transfer in the rodent brain.

Stott SR, Kirik D.

Eur J Neurosci. 2006 Oct;24(7):1897-906.

PMID:
17067293

Supplemental Content

Loading ...
Support Center